Kensey Nash Corporation - KNSY- Profile

Kensey Nash Corporation. The Group's principal activities is to design develop and market various absorbable polymer and collagen products. These products are used in numerous applications including orthopaedic, cardiology, drug/biologics delivery, periodontal, general surgery and wound care. It has developed the Angio-Seal(R) vascular closure device, which is used to seal and close femoral artery punctures made during diagnostic and therapeutic cardiovascular catheterizations. Angio-Seal(R) vascular closure device is marketed, manufactured and distributed by St. Jude Medical under a license agreement. Its endovascular product platform includes the TriActiv FX(R)Embolic Protection System, the triActiv(R)ProGuardTMSystem , the QuickCatTMExtraction Catheter and ThromCatTMThrombectomy Catheter System devices. The Group's Products are marketed to hospitals throughout the United States and Europe. In May-2006, it acquired IntraLuminal Therapeutics, Inc. Designs develops and markets various absorbable polymer and collagen products